Live Breaking News & Updates on உலகம் பொருளாதார மன்றம் தொழில்நுட்பம் முன்னோடி விருது

Stay updated with breaking news from உலகம் பொருளாதார மன்றம் தொழில்நுட்பம் முன்னோடி விருது. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Hemostemix Inc.: Hemostemix Announces Closing of First Tranche of Unit Private Placement

Hemostemix Inc.: Hemostemix Announces Closing of First Tranche of Unit Private Placement
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

United States , Thomas Smeenk , Regulation Service Provider , Common Shares Of The Company , World Economic Forum Technology Pioneer Award , Hemostemix Inc , Alberta Newsfile Corp , Venture Exchange , Company Common Share , Each Unit , Common Share , Common Shares , Ischemic Cardiomyopathy , Dilated Cardiomyopathy , Stem Cell Treatment , Regulating Stem Cells , Vitro Techniques , Neural Lineage , Automated Cell , Looking Information , ஒன்றுபட்டது மாநிலங்களில் , ஒழுங்குமுறை சேவை வழங்குநர் , பொதுவானது பங்குகள் ஆஃப் தி நிறுவனம் , உலகம் பொருளாதார மன்றம் தொழில்நுட்பம் முன்னோடி விருது , துணிகர பரிமாற்றம் , நிறுவனம் பொதுவானது பகிர் ,

Hemostemix Inc.: Hemostemix Announces Warrant Repricing and Extension

Hemostemix Inc.: Hemostemix Announces Warrant Repricing and Extension
Calgary, Alberta (Newsfile Corp. - July 5, 2021) - Hemostemix Inc. (TSXV: HEM) (OTC: HMTXF) (FSE: 2VFO) ( Hemostemix or the Company ) is pleased to announce, subject to TSX Venture Exchange Approval, that it has extended for two years and repriced to $0.55 from $1, subject to the accelerator provisions stated below on all repriced warrants, 1,332,500 Warrants expiring July 9, 2021; extended 918,450 Warrants expiring November 24, 2021 of which 510,295 Warrants are repriced to $0.55 (408,155 Warrants held by insiders not repriced from $1); extended 6,360,585 Warrants expiring December 18, 2021, repricing 4,733,559 Warrants (1,627,026 Warrants held by insiders are not repriced from $1); extended 9,166,667 Warrants expiring December 31, 2021, repricing 8,513,334 Warrants (653,333 Warrants held by insiders not repriced from $1). ....

United States , Thomas Smeenk , World Economic Forum Technology Pioneer Award , Hemostemix Inc , Company Counsel , Venture Exchange Approval , Regulation Service Provider , Alberta Newsfile Corp , Venture Exchange , Exchange Approval , Multilateral Instrument , Minority Shareholders , Special Transactions , Ischemic Cardiomyopathy , Dilated Cardiomyopathy , Stem Cell Treatment , Regulating Stem Cells , Vitro Techniques , Stem Cells , Neural Lineage , Automated Cell , Looking Information , Common Shares , ஒன்றுபட்டது மாநிலங்களில் , உலகம் பொருளாதார மன்றம் தொழில்நுட்பம் முன்னோடி விருது , நிறுவனம் ஆலோசனை ,

Hemostemix Inc.: Hemostemix Announces the Closing of a $2,500,000 Convertible Debenture

Calgary, Alberta (Newsfile Corp. - June 11, 2021) - Hemostemix Inc. (TSXV: HEM) (OTC: HMTXF) (FSE: 2VFO) ("Hemostemix" or the "Company") is pleased to announce that it closed its previously announced ....

United States , South Africa , Thomas Smeenk , Delaware Federal Court , Venture Exchange The , Common Shares Of The Company Debenture , Regulation Service Provider , Common Shares Of The Company , World Economic Forum Technology Pioneer Award , Hemostemix Inc , Company For Debenture Units , Florida State Court , Alberta Newsfile Corp , Venture Exchange , Board Of Directors The Company , Debenture Units , Each Debenture Unit , Common Shares , Common Share , Market Price , Conversion Price , Each Debenture Warrant , Debenture Offering , Debenture Warrants , Minority Security Holders , Special Transactions ,

Hemostemix Inc.: Hemostemix Announces that, Due to the COVID-19 Pandemic, the Annual and Special Meeting Will Only Be Held via Zoom and Shareholders are Requested to Follow the Meeting Instructions Mailed to the Shareholders of Record

Calgary, Alberta (Newsfile Corp. - May 31, 2021) - Hemostemix Inc. (TSXV: HEM) (OTC Pink: HMTXF) (FSE:2VF0) ("Hemostemix" or the "Company") reminds shareholders that due to COVID-19, its Annual and ....

Thomas Smeenk , World Economic Forum Technology Pioneer Award , Hemostemix Inc , Meeting Of The Shareholders Hemostemix Inc , Regulation Service Provider , Alberta Newsfile Corp , Venture Exchange , Special Meeting , New York , San Jose , Ischemic Cardiomyopathy , Dilated Cardiomyopathy , Stem Cell Treatment , Looking Information , Debenture Offering , Common Shares , உலகம் பொருளாதார மன்றம் தொழில்நுட்பம் முன்னோடி விருது , ஒழுங்குமுறை சேவை வழங்குநர் , துணிகர பரிமாற்றம் , சிறப்பு சந்தித்தல் , புதியது யார்க் , சான் ஜோசே , தண்டு செல் சிகிச்சை , பார்க்கிறது தகவல் , பொதுவானது பங்குகள் ,

Hemostemix : Announces the TSX Venture's Preliminary Approval of the Closing of a $2,500,000 Convertible Debenture at $0.40 per Unit and Corporate Update

Hemostemix Announces the TSX Venture s Preliminary Approval of the Closing of a $2,500,000 Convertible Debenture at $0.40 per Unit and Corporate Update

May 29, 2021

Calgary,. | May 30, 2021 ....

United States , Thomas Smeenk , World Economic Forum Technology Pioneer Award , Hemostemix Inc , Polices Of The Exchange , Common Shares Of The Company Debenture , Venture Exchange , Common Shares Of The Company , Hemostemix Announces , Preliminary Approval , Corporate Update , Debenture Units , Financial Statements , Management Discussion , Debenture Offering , Debenture Unit , Each Debenture Unit , Debenture Warrant , Common Share , Common Shares , Debenture Warrants , Maturity Date , Debenture Shares , Conversion Price , Market Price , United States Securities Act ,